Tijaabo Caafimaad oo Cusub oo loogu talagalay Daawaynta Kansarka qanjirka 'prostate'

January 21, 2022
by editor
Add Comment
2 min akhris
en English
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laola Latinlv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sudanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu
Written by editor

Hinova Pharmaceuticals Inc., oo ah shirkad heer-caafimaad biopharmaceutical ah oo diiradda saarey horumarinta daaweynta cusub ee kansarrada iyo cudurrada dheef-shiid kiimikaadka iyada oo loo marayo tignoolajiyada burburinta borotiinka, ayaa ku dhawaaqday in bukaankii ugu horreeyay ee qaba kansarka qanjirka 'prostate-u adkeysiga dheef-shiid kiimikaadka' Tijaabada caafimaad ee HP518, aad loo xushay oo afka laga heli karo kimeric degrader oo bartilmaameedsanaysa soo-dhowaynta androgen (AR). Summada furan ee socota ee Wajiga I ee Australia waxay qiimeyn doontaa badbaadada, farmashiyaha, iyo waxqabadka ka hortagga burada ee HP518 ee bukaannada qaba mCRPC.

Print Friendly, PDF & Email

HP518 waxa la helay oo soo saartay Hinova bartilmaansaneed ee burburinta borotiinka madal daahfurka daroogada. Waxay awood u leedahay inay ka gudubto iska caabbinta daawada kansarka qanjirka 'prostate' sababtoo ah isbeddellada AR ee gaarka ah.

Degraders Chimeric waa unugyo yaryar oo laba-shaqeeya kuwaas oo kor u qaada hoos u dhaca borotiinada bartilmaameedka leh ee leh awood sare iyo xulashada sare. Tignoolajiyadani waxay awood u leedahay inay beegsato bartilmaameedyada aan dawada lahayn iyo inay ka gudubto arrinta iska caabbinta daroogada ee dawooyinka molecule-yar ee dhaqameed.

"Tani waa guul muhiim ah oo laga gaaray horumarka dadaalkeena laga soo bilaabo baarista daroogada ilaa daraasadda bukaan-socodka," ayuu yiri Yuanwei Chen, Ph.D., Madaxweynaha iyo Maamulaha Hinova. "Waan ku faraxsanahay arrintaas waxaana u heellan inaan u keeno doorashooyin cusub oo daweyn bukaannada adduunka oo dhan!"

Iyada oo loo marayo goobta lagu helayo dawada baabi'isa borotiinka, Hinova waxay si degdeg ah u eegi kartaa nashaadaynta borotiinka waxayna ku guulaysan kartaa naqshad hufan iyo hagaajinta kuwa wax-jabiya chimeric. Intaa waxaa dheer, Hinova waxay khibrad qoto dheer u leedahay xakamaynta soo saarista kiimikaad ee xeryahooda degrader.

Print Friendly, PDF & Email

Waxaa kaloo laga yaabaa

War ku saabsan qoraaga

editor

Tifaftiraha madaxa eTurboNew waa Linda Hohnholz. Waxay ku salaysan tahay eTN HQ ee Honolulu, Hawaii.

Eeg dhammaan qoraalada

Leave a Comment